RIO DE JANEIRO, BRAZIL - Company Pideka completed its first commercial shipment of medical cannabis with THC from its crops grown in Tocancipá (Cundinamarca) to Mexico.
According to company estimates, this market could represent US$20 billion in the next five years and has close to 1 million potential patients eligible for treatment with these components.
The company also expects to be a major player in Europe and to multiply the number of jobs in . . .